Inside STAT: A guide to how — and when — a Covid-19 vaccine could be cleared

As Election Day in the U.S. approaches, talk of a Covid-19 vaccine has become even more fervent, even though it's highly unlikely a vaccine will be ready in the next six weeks. Already, these lofty promises about an accelerated timeline seem to have eroded public trust in the process, as fewer people in the U.S. share with pollsters that they will be ready to take a vaccine when it becomes available. In a new story, STAT's Matthew Herper outlines the vaccine development process, including when those making one will have enough data for approval, and what the rules for approval will be. "[I]t’s important to understand it if we are to have confidence in these critical tools for helping to curb the pandemic," he writes. More here.